Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury.
Ontology highlight
ABSTRACT: Renal ischemia-reperfusion injury (IRI) is one of the most common causes of acute kidney injury (AKI). It poses a significant threat to public health, and effective therapeutic drugs are lacking. Mefunidone (MFD) is a new pyridinone drug that exerts a significant protective effect on diabetic nephropathy and the unilateral ureteral obstruction (UUO) model in our previous study. However, the effects of mefunidone on ischemia-reperfusion injury-induced acute kidney injury remain unknown. In this study, we investigated the protective effect of mefunidone against ischemia-reperfusion injury-induced acute kidney injury and explored the underlying mechanism. These results revealed that mefunidone exerted a protective effect against ischemia-reperfusion injury-induced acute kidney injury. In an i
SUBMITTER: Li J
PROVIDER: S-EPMC9727196 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA